Mark is heavily involved in many areas of work for the Continuous Mortality Investigation (CMI) as well as mortality experience analyses, index calculation and assumptions derivation.
As well as his CMI involvement, Mark has been extensively involved in projects to develop mortality assumptions for Enhanced Annuity providers and reviewing insurers’ models of future mortality improvements.
Mark has also performed a variety of Life Insurance roles for our Insurance Consulting practice, including spending three months on secondment managing the year-end valuation of a UK life insurance company.
Smoking kills. No surprises there. It has also been recognised in the pricing of term insurance in the UK since the early 1980s and more recently in annuity pricing. But what do we know about the impact of smoking on mortality improvements?
The adverse impact of smoking on life expectancy has been widely-recognised for many years. Our analysis suggests that around 20% of the observed improvements in UK mortality in recent decades can be attributed to reductions in smoking.
After many years of rapid mortality improvements in the UK population, 2012 and 2013 saw significantly lower gains.